Sleep studies often pose challenges for diagnosing nighttime cardiac issues due to their tendency to be time-consuming and anxiety-inducing, particularly for those with sleep difficulties. Remote telemetry devices can assist clinicians to address this by providing continuous cardiac monitoring from a patient’s home during both awake and sleep hours. Remote monitoring solutions that can provide both sleep study capability and diagnostic arrhythmia detection, unlike one-night studies in a facility, would offer ongoing monitoring, allowing clinicians to gather more comprehensive data on heart activity and sleep patterns over time. This continuous monitoring detects abnormalities like oxygen drops and heart rate fluctuations, enabling early detection of arrhythmias like AFib and bradyarrhythmia, which are often worsened by poor sleep.6
Most powerfully, virtual telemetry can be coupled with artificial intelligence (AI)-powered analysis to transform large volumes of high-acuity data into instant clinical insight. Advanced AI algorithms process and interpret patient data in near real-time, identifying trends and providing clinicians with actionable information for more precise and personalized care.
Together, remote monitoring and AI-powered analysis are aimed at driving improved outcomes for both heart health and sleep-related disorders. One study reported that heart failure patients who used wearable devices to track their sleep patterns had a 25% reduction in hospital admissions for heart-related events compared to those receiving standard care.7
About the Author
Stuart Long is the CEO of InfoBionic.Ai, a position he has held since March 2017. He underscores the company’s commitment to widespread market adoption of its transformative wireless remote patient monitoring platform for chronic disease management.
Using AI-Powered Virtual Cardiac Telemetry for Nocturnal Cardiac Conditions
So far, we’ve established the strength of the heart-sleep connection and discussed how virtual telemetry and AI-powered analysis shed new light on the relationship between these 2 critical functions. But what does this look like in practice? And how can these technologies be used to improve outcomes for specific cardiac conditions? Let’s review 3 use cases.
- Early Detection of Nocturnal Arrhythmias
Conditions like nocturnal AFib and bradyarrhythmia often escape detection in standard, time-limited electrocardiograms (ECGs), which tend to miss arrhythmias triggered by shifts between rapid eye movement (REM) and non-REM sleep. During REM sleep, the autonomic nervous system becomes more active, which can lead to increased heart rate variability and predispose certain patients to AFib or ventricular arrhythmias.
Virtual cardiac telemetry provides clinicians with continuous ECG data by using wearable sensors that monitor heart activity 24/7, including during sleep. By capturing data throughout the entire sleep cycle, it allows for the detection of nocturnal arrhythmias that may only occur during specific phases, offering a comprehensive view of the patient’s cardiovascular function.
- Managing Sleep Apnea and Cardiac Risk Factors
Patients with OSA are at a heightened risk for AFib, heart failure, and hypertension due to repeated nocturnal hypoxia and sympathetic nervous system activation. In fact, nocturnal AFib is up to 4 times more prevalent in patients with OSA.7
Virtual cardiac telemetry, when combined with dedicated sleep study monitoring, can play a pivotal role in capturing the physiological effects of OSA on the cardiovascular system in near real-time, especially during events. This could enable clinicians a closer examination of how intermittent hypoxia during apnea episodes might affect heart rhythms, and whether arrhythmias are more likely to occur after episodes of oxygen desaturation. Providers can track patient response to positive airway pressure therapy by correlating improved oxygenation with reductions in arrhythmia frequency or severity, thus informing decisions on continuous positive airway pressure adherence or alternative treatments.
Continuous data streams also enable clinicians to assess whether to initiate or modify medications such as beta-blockers or anti-arrhythmic drugs, particularly in patients whose heart rate and rhythm vary during apneic episodes.
- Optimizing Medication Timing Based on Circadian Rhythms
The circadian system plays a fundamental role in regulating cardiovascular functions, with heart rate and blood pressure naturally dipping during sleep. However, in patients with cardiovascular conditions like hypertension or AFib, this natural rhythm can be disrupted, contributing to non-dipping blood pressure or nocturnal arrhythmias.
Virtual cardiac telemetry enables clinicians to monitor patients in near real-time and to gain more insights that could include optimizing the timing of medications for improved therapeutic outcomes. For example, chronotherapy (timing medications in alignment with circadian rhythms) can be informed by data showing when patients are most vulnerable to arrhythmias or elevated blood pressure. This allows providers to adjust the administration of beta-blockers, antihypertensives, or anticoagulants to ensure optimal drug efficacy during sleep periods when cardiac events may occur.8
Additionally, research suggests that synchronizing the delivery of medications with specific periods of risk can significantly reduce the likelihood of adverse events, including stroke and myocardial infarction.8 Virtual cardiac telemetry provides the necessary data to inform these precision medicine approaches.
Sleep Tight: Embracing the Future of Remote Monitoring and Sleep-Related Heart Health
Sleep is more than just a time for rest—it’s a critical factor in cardiovascular health. By uncovering the hidden relationship between sleep patterns and cardiac indicators, remote cardiac monitoring offers the potential for earlier diagnosis, more personalized treatment, and better outcomes.
As remote monitoring technology evolves, AI-driven insights and wearable devices will play a pivotal clinical role. Finally, advanced diagnostics of sleep-related cardiac conditions will be possible outside the traditional sleep clinic, from nearly anywhere. Both patients and providers will rest easier as these sleep-related cardiac conditions are proactively identified and managed, helping to address one of the most overlooked contributors to cardiovascular disease.
REFERENCES
1. Rogers K. What a weekend snooze could do for your heart health, according to new research. CNN. August 30, 2024. https://www.cnn.com/2024/08/30/health/weekend-sleep-lower-heart-disease-risk-wellness/index.html
2. Insomnia and Heart Health. American Heart Association. June 28, 2023. https://www.heart.org/en/health-topics/sleep-disorders/insomnia
3. AFib. Cleveland Clinic. July 25, 2024. https://my.clevelandclinic.org/health/diseases/16765-atrial-fibrillation-afib
4. Sleep Science and Sleep Disorders. National Heart, Lung, and Blood Institute. Accessed September 16, 2024.https://www.nhlbi.nih.gov/science/sleep-science-and-sleep-disorders
5. Atrial Fibrillation and Sleep Apnea: What You Need to Know. Heart Rhythm Society. Accessed September 16, 2024. https://www.hrsonline.org/documents/atrial-fibrillation-and-sleep-apnea/download
6. Mehra R, Chung M, Olshansky B, et al. Sleep-Disordered Breathing and Cardiac Arrhythmias in Adults: Mechanistic Insights and Clinical Implications: A Scientific Statement From the American Heart Association.Circulation. August 1, 2022. https://www.ahajournals.org/doi/10.1161/CIR.0000000000001082
7. Lin CH, Timofeeva M, O’Brien T, et al. Obstructive sleep apnea and nocturnal attacks of paroxysmal atrial fibrillation. Journal of Clinical Sleep Medicine. May 1, 2022. https://jcsm.aasm.org/doi/full/10.5664/jcsm.9840
8. Hermida R, Crespo J, Dominguez-Sardina M, et al. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial. European Heart Journal. December 21, 2020. https://academic.oup.com/eurheartj/article/41/48/4565/5602478?login=false